ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.

NSC Compound Enrichment Correlation
NSC 73735 B 3845 0.00725424828633685 0.5388175
NSC 757113 METHOTREXATE(+/-) 0.00725424828633685 0.4753928
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.00957309511256283 0.37038849
NSC 699921 Null 0.00995118568011482 0.34226355
NSC 81052 Streptonigrin analog (MeO-N3) 0.00995118568011489 0.37768619
NSC 100880 Camptothecin 0.0105244982742819 0.52353116
NSC 105014 Cladribine 0.0105244982742819 0.35660016
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0105244982742819 0.31802685
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0105244982742819 0.45119305
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0105244982742819 0.46638354
Total:67  Current:18    [First] [Prev] [Next] [Last]